Dr. Jill C. Beck
Claim this profileChildren's Hospital and Medical Center of Omaha
Expert in Tumors
Expert in Brain Tumor
50 reported clinical trials
105 drugs studied
About Jill C. Beck
Education:
- Obtained MD (Doctor of Medicine) from the University of Nebraska Medical Center in 1997.
- Completed Residency in Pediatrics at the University of Nebraska Medical Center, Children's Hospital & Medical Center in 2000.
- Concluded Fellowship in Pediatric Hematology/Oncology at the University of Nebraska Medical Center, Children's Hospital & Medical Center in 2003.
Experience:
- Currently serves as a pediatric hematologist/oncologist at Children's Hospital and Medical Center of Omaha.
Area of expertise
1Tumors
Global LeaderStage I
Stage IV
Stage II
2Brain Tumor
Global LeaderStage I
Stage II
Stage IV
Affiliated Hospitals
Clinical Trials Jill C. Beck is currently running
Selumetinib vs. Chemotherapy
for Brain Cancer
This trial is comparing a new drug, selumetinib, with standard chemotherapy to treat patients with a specific type of brain tumor. The patients do not have a certain genetic mutation and are not affected by a genetic disorder. Selumetinib works by blocking enzymes needed for tumor growth, while the standard drugs kill or stop tumor cells from dividing.
Recruiting2 awards Phase 3
Genetic Testing-Directed Therapy
for Pediatric Cancer
This Pediatric MATCH screening and multi-sub-study phase II trial studies how well treatment that is directed by genetic testing works in pediatric patients with solid tumors, non-Hodgkin lymphomas, or histiocytic disorders that have progressed following at least one line of standard systemic therapy and/or for which no standard treatment exists that has been shown to prolong survival. Genetic tests look at the unique genetic material (genes) of patients' tumor cells. Patients with genetic changes or abnormalities (mutations) may benefit more from treatment which targets their tumor's particular genetic mutation, and may help doctors plan better treatment for patients with solid tumors or non-Hodgkin lymphomas.
Recruiting1 award Phase 214 criteria
More about Jill C. Beck
Clinical Trial Related4 years of experience running clinical trials · Led 50 trials as a Principal Investigator · 25 Active Clinical TrialsTreatments Jill C. Beck has experience with
- Cyclophosphamide
- Radiation Therapy
- Etoposide
- Doxorubicin Hydrochloride
- Cisplatin
- Methotrexate
Breakdown of trials Jill C. Beck has run
Tumors
Brain Tumor
Cancer
Neuroblastoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Jill C. Beck specialize in?
Jill C. Beck focuses on Tumors and Brain Tumor. In particular, much of their work with Tumors has involved Stage I patients, or patients who are Stage IV.
Is Jill C. Beck currently recruiting for clinical trials?
Yes, Jill C. Beck is currently recruiting for 22 clinical trials in Omaha Nebraska. If you're interested in participating, you should apply.
Are there any treatments that Jill C. Beck has studied deeply?
Yes, Jill C. Beck has studied treatments such as Cyclophosphamide, Radiation Therapy, Etoposide.
What is the best way to schedule an appointment with Jill C. Beck?
Apply for one of the trials that Jill C. Beck is conducting.
What is the office address of Jill C. Beck?
The office of Jill C. Beck is located at: Children's Hospital and Medical Center of Omaha, Omaha, Nebraska 68114 United States. This is the address for their practice at the Children's Hospital and Medical Center of Omaha.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.